1-3 of 3
Michael Abecassis, MD
Close
Sort by
Journal Articles

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Joseph R. Leventhal, MD PhD, John P. Galvin, MDMS,MPH, James Mathew, PhD, Lorenzo Gallon, MD, Kadiyala Ravindra, MD, Mitchell E. Horwitz, MD, Michael Abecassis, MD, MBA, Suzanne T Ildstad, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 202.
https://doi.org/10.1182/blood-2018-99-118832
Published: 2018
Journal Articles

Update On Phase 2 Clinical Trial To Induce Tolerance In Mismatched Living Donor Renal Transplant Recipients

Joseph Leventhal, MD, PhD, Michael Abecassis, MD, Joshua Miller, MD, Lorenzo Gallon, MD, David J Tollerud, MD, MPH, Suzanne T. Ildstad, MD
Journal: Blood
Blood (2013) 122 (21): 4622.
https://doi.org/10.1182/blood.V122.21.4622.4622
Published: 2013
Journal Articles

Chimerism and Tolerance Without Gvhd In Mismatched Recipients Of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker For Tolerance

Joseph Leventhal, MD, PhD, Michael Abecassis, MD, Joshua Miller, MD, Lorenzo Gallon, MD, David J. Tollerud, MD, MPH, Mary Jane Elliott, M.S., Suzanne T. Ildstad, M.D.
Journal: Blood
Blood (2013) 122 (21): 912.
https://doi.org/10.1182/blood.V122.21.912.912
Published: 2013